证券代码：601567 证券简称：三星医疗 公告编号：临 2024-095 宁波三星医疗电气股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 投资种类：安全性高、流动性好、低风险的理财产品。 特别风险提示：公司委托理财的投资范围主要是安全性高、流动性好、 低风险的理财产品，但金融市场受宏观经济影响较大，不排除相关投资可能会受 到市场波动风险、政策风险、流动性风险、不可抗力风险等因素影响，实际收益 存在不确定性。敬请广大投资者注意投资风险。 一、投资情况概述 （一）投资目的 关于使用闲置自有资金委托理财额度的公告 投资金额：公司及子公司拟使用不超过人民币 15 亿元闲置自有资金进行 委托理财，投资期限不超过 12 个月，期限内任一时点的交易金额不超过上述委 托理财额度（含前述投资的收益进行再投资的相关金额）。 已履行的审议程序：2024 年 8 月 22 日，宁波三星医疗电气股份有限公 司（以下简称"公司"）召开第六届董事会第十七次会议，审议通过了《关于使用 闲置自有资金委托理财额度的议案》，本事 ...

宁波三星医疗电气股份有限公司 ESG 管理办法 第一章 总则 第一条 为加强宁波三星医疗电气股份有限公司（以下简称"公司"）ESG 管理，强化公司ESG自我约束机制，积极履行ESG职责，推进公司落实科学发 展观，实现可持续发展，根据证监会《上市公司治理准则》，生态环境部《企 业环境信息依法披露管理办法》，上海证券交易所《上海证券交易所上市公司 自律监管指引第1号——规范运作》《上海证券交易所上市公司自律监管指引第 2号——信息披露事务管理》，以及《宁波三星医疗电气股份有限公司信息披露 管理办法》等的相关规定，制定本办法。 第二条 本办法适用于公司及纳入公司合并报表范围内的全资、控股子公司 （以下简称"子公司"）。 第三条 本办法所称ESG职责，是指公司在经营发展过程中应当履行的环境 （Environmental）、社会（Social）和公司治理（Governance）方面的责任和义 务，主要包括对自然环境和资源的保护、社会责任的承担以及公司治理的健全 和透明。 本办法所称利益相关方，是指其利益可能受到公司决策或经营活动影响的 组织或个人，包括股东（投资者）、债权人、职工、合作伙伴、客户、供应商、 社区组织和相 ...

证券代码：601567 证券简称：三星医疗 公告编号：临 2024-089 重要内容提示: ● 被担保人名称：Foxytech Sp.zo.o（以下简称"福克斯"） ● 本次担保金额及已实际为其担保的余额 公司预计对子公司提供担保额度不超过 953,350 万元，其中为福克斯提供 3,000 万元担保额度，截至本公告披露日，已实际为福克斯提供的担保余额约为 212.01 万美 元，按保函开具当日汇率换算，约为 1513.92 万人民币（含本次担保）。 宁波三星医疗电气股份有限公司 关于为子公司提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 二、被担保人基本情况 ● 本次是否有反担保：无 ● 对外担保逾期的累计金额：无 一、担保情况概述 （一）担保基本情况 因子公司业务需要，宁波三星医疗电气股份有限公司（以下简称"公司"）于近日 作为申请人向汇丰银行（中国）有限公司宁波分行申请开立了保函，保函金额合计约 99.18 万美元（按保函开具当日汇率换算，约为 708.09 万人民币），为 HSBC Continen ...

宁波三星医疗电气股份有限公司 关于子公司签订海外经营合同的公告 证券代码：601567 证券简称：三星医疗 公告编号：临 2024-090 二、合同对方当事人情况 公司名称：DISTRIBUCIONES CANTILEVER S DE RL DE CV 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 宁波三星医疗电气股份有限公司（以下简称"公司"）全资子公司宁波奥克斯智能 科技股份有限公司（以下简称"奥克斯智能科技"）在墨西哥Distribution Transformers Deserted Items 2023招标项目中中标配电变压器项目，合同金额总计1117.12万美元， 约合7931.55万人民币。具体情况如下： 一、交易概述 奥克斯智能科技在墨西哥Distribution Transformers Deserted Items 2023项目中中 标配电变压器项目，奥克斯智能科技作为供应商，提供配电变压器产品，合同金额总 计1117.12万美元，约合7931.55万人民币。 2、合同金额：合同金额总计1 ...

Financial Data and Key Metrics Changes - The company is projected to achieve a net profit of approximately 2.37 billion in 2024, with expectations of 2.83 billion in 2025 and 3.58 billion in 2026, indicating a compound annual growth rate of over 20% [45] - The current market capitalization is around 40 billion, with a price-to-earnings ratio of approximately 18 times for this year and potentially 14 to 15 times for next year [12][45] Business Line Data and Key Metrics Changes - The domestic electric meter business is expected to maintain a stable growth rate of 5% to 10% over the next few years, benefiting from a solid market position and consistent demand [4][5] - The domestic distribution transformer business is projected to grow at a compound annual growth rate of 25% to 35% over the next three years, driven by the expansion of the renewable energy market [5] - The overseas electric meter business is anticipated to grow at a compound annual growth rate exceeding 30% in the coming years, supported by increasing electricity demand and the penetration of smart meters [7][10] - The medical business is expected to maintain a stable growth rate of 20% to 30% [11] Market Data and Key Metrics Changes - The global electric equipment market is estimated to maintain a capital expenditure of around 300 billion USD, with significant investments in both developed and developing countries [20][21] - In Europe, the capital expenditure for distribution networks is projected to remain above 60%, indicating a strong focus on upgrading aging infrastructure [23] Company Strategy and Development Direction - The company is focusing on dual main business development in electric equipment and medical services, with a strong emphasis on expanding its overseas market presence [15][43] - The company aims to leverage its established brand and distribution channels to enhance its market share in the overseas electric meter and distribution equipment sectors [31][32] - The company is actively pursuing opportunities in emerging markets, particularly in Southeast Asia and the Middle East, where demand for smart meters and distribution equipment is rapidly increasing [28][25] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's growth trajectory, highlighting the robust demand for electric equipment and the potential for significant market expansion in overseas markets [12][10] - The management noted that the company has a solid order backlog of over 5 billion, indicating strong future revenue potential [10] - The management emphasized the importance of technological advancements and the shift towards smart grid solutions as key drivers for future growth [36][37] Other Important Information - The company has established five manufacturing bases overseas, with ongoing expansions in Germany and Mexico, enhancing its global production capabilities [31] - The company has a strong commitment to shareholder returns, maintaining a dividend payout ratio above 30% [16] Q&A Session Summary Question: What is the outlook for the company's overseas expansion? - The company is optimistic about its overseas electric meter and distribution business, expecting significant growth driven by increasing demand in emerging markets [10][32] Question: How does the company plan to address the challenges in the domestic market? - The company is focusing on capitalizing on the current replacement cycle for electric meters, which is expected to contribute positively to its performance this year [33] Question: What are the key growth areas for the medical business? - The medical business is seen as a long-term growth area, with plans to expand its network of rehabilitation hospitals and improve operational efficiency [44]

Financial Data and Key Metrics Changes - The company is projected to achieve a net profit of approximately 2.37 billion in 2024, with expectations of 2.83 billion in 2025 and 3.58 billion in 2026, indicating a compound annual growth rate of over 20% [45][46] - The current market capitalization is around 40 billion, with a price-to-earnings ratio of approximately 18 times for this year and potentially 14 to 15 times for next year [12][46] Business Line Data and Key Metrics Changes - The domestic electricity meter business is expected to maintain a stable growth rate of 5% to 10% over the next few years, supported by a solid market share and profitability [4][5] - The domestic distribution transformer business is projected to grow at a compound annual growth rate of 25% to 35% over the next three years, benefiting from the expansion of the renewable energy market [5][10] - The overseas electricity meter business is anticipated to grow at a compound annual growth rate exceeding 30% in the coming years, driven by increasing electricity demand and the penetration of smart meters [7][10] - The medical business is expected to maintain a stable growth rate of 20% to 30% [11] Market Data and Key Metrics Changes - The global electricity equipment market is estimated to maintain a capital expenditure of around 300 billion USD, with significant investments in distribution networks in developed countries [20][21] - In Europe, the capital expenditure for distribution networks is projected to remain above 60%, indicating a strong focus on upgrading aging infrastructure [23][24] Company Strategy and Development Direction - The company is focusing on dual main business development in electricity equipment and medical services, with a strong emphasis on expanding its overseas market presence [15][43] - The company aims to leverage its established brand and distribution channels to enhance its market share in both domestic and international markets [13][31] - The strategy includes continuous investment in talent development and maintaining a high dividend payout ratio to ensure shareholder returns [16][44] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's growth trajectory, with expectations of a 20% to 30% growth rate over the next three years [12][42] - The management highlighted the importance of overseas markets, particularly in regions like Europe and the Middle East, where demand for smart meters and distribution equipment is expected to surge [10][32] - The management noted that the company has a solid order backlog of over 5 billion, indicating strong future revenue potential [10] Other Important Information - The company has established five manufacturing bases overseas, with ongoing expansions in Germany and Mexico, enhancing its global footprint [31] - The company has successfully entered the Saudi Arabian market and achieved breakthroughs in Europe, indicating a growing international presence [10][32] Q&A Session Summary Question: What is the outlook for the company's overseas business? - The overseas electricity meter business is expected to grow at a compound annual growth rate exceeding 30%, driven by increasing demand and market penetration [7][10] Question: How does the company plan to maintain its competitive edge? - The company plans to leverage its established brand and distribution channels while continuously investing in talent and technology to enhance its competitive position [16][31] Question: What are the expected growth rates for the domestic market? - The domestic electricity meter business is projected to grow at 5% to 10%, while the distribution transformer business is expected to see a growth rate of 25% to 35% [4][5][10]

Summary of Conference Call Company and Industry Involved - The conference call involved Dongwu Securities and focused on the telecommunications and medical sectors, specifically mentioning Samsung Medical [1]. Core Points and Arguments - The call was structured to provide deep updates on the telecommunications and medical industries, indicating a focus on current trends and developments within these sectors [1]. - It was emphasized that the information shared during the call is intended for institutional investors or invited clients, highlighting the exclusivity of the insights provided [1]. - The call included a disclaimer that the opinions expressed by third-party experts are personal and do not constitute investment advice for specific securities at specific price levels [1]. Other Important but Possibly Overlooked Content - The call began with a welcome message and a reminder about the muted status of all participants, indicating a formal and structured approach to the meeting [1]. - The mention of the call being directed at institutional investors suggests a focus on high-level analysis and insights that may not be available to the general public [1].

Group 1: Business Expansion and Market Presence - The company currently does not operate in North America but is focusing on Europe, the Middle East, and actively expanding into Latin America, Asia-Pacific, and Africa, with a mature sales network covering multiple countries and regions globally [1] - The company has established overseas production bases in Brazil, Indonesia, Poland, and recently added facilities in Germany and Mexico, with the German factory progressing as planned to serve the European market [2] Group 2: Tender and Contract Achievements - The company has been recommended as a candidate for the first batch of framework tender projects for metering products and distribution network equipment in the Southern Power Grid for 2024, with an expected tender amount of approximately ¥629 million [2] - The pre-tender amount for metering products is approximately ¥380 million, representing a year-on-year increase of 108.12%, while the pre-tender amount for distribution network equipment is approximately ¥249 million, showing a year-on-year increase of 39.64% [2] Group 3: Order Delivery and Hospital Network - The typical order delivery cycle for the company is 1-2 years, with variations in delivery rhythm based on customer requirements and product types [2] - As of the end of 2023, the company operates 28 hospitals, including 22 rehabilitation hospitals, with a total of over 8,800 beds, primarily located in key cities in East, Central, and South China [2]

上海市锦天城律师事务所 关于宁波三星医疗电气股份有限公司 2024 年第三次临时股东大会的 法律意见书 锦 天 斌 律师事务 所 ALLBRIGHT LAW OFFICES 关于宁波三星医疗电气股份有限公司 2024 年第三次临时股东大会的 法律意见书 致:宁波三星医疗电气股份有限公司 上海市锦天城律师事务所(以下简称"本所")接受宁波三星医疗电气股份 有限公司(以下简称"公司")委托,就公司召开2024年第三次临时股东大会 (以下简称"本次股东大会")的有关事宜,根据《中华人民共和国公司法》(以 下简称《公司法》) 《上市公司股东大会规则》等法律、法规、规章和其他规范 性文件以及《宁波三星医疗电气股份有限公司章程》(以下简称《公司章程》) 的有关规定,出具本法律意见书。 地址: 上海市浦东新区银城中路 501 号上海中心大厦 11/12 楼 电话: 021-20511000 传真: 021-20511999 邮编: 200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 为出具本法律意见书. 本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则(试行 ...

证券代码：601567 证券简称：三星医疗 公告编号：临 2024-088 宁波三星医疗电气股份有限公司 2024 年第三次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2024 年 7 月 22 日 (二)股东大会召开的地点：宁波市鄞州区首南街道日丽中路 757 号奥克斯中央大 厦 25 楼会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 141 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 770,919,163 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 55.0780 | 注：上表中公司有表决权股份总数不含公司回购账户中的股份数，本次已剔除。 (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会由公司董事会召 ...